0 Table of Contents |
1 AdverseEvents for Clinical Research Home Page |
2 Background and Workflow |
3 Real World examples |
3.1 Cancer Clinical Trial Example |
4 Security Note |
5 Useful Downloads |
6 IG Change History |
7 Artifacts Summary |
7.1 Adverse Event Clinical Research |
7.2 Adverse Event Grade |
7.3 Adverse event caused subject to discontinue the study |
7.4 Contributing Factor |
7.5 Expected In Research Study |
7.6 Mitigating Action |
7.7 Note |
7.8 Participant |
7.9 Research Subject record of subject |
7.10 Adverse Event resolution date |
7.11 Resulting Effect |
7.12 Criteria reviewed in determining serious adverse event |
7.13 Workflow Status |
7.14 Supporting information relevant to the event |
7.15 Suspect Entity |
7.16 AdverseEvent Contributing Factor |
7.17 AdverseEvent Mitigating Action |
7.18 Adverse Event Participant Functions |
7.19 AdverseEvent Seriousness Non-serious Codes Only |
7.20 Adverse Event Status |
7.21 AdverseEvent Supporting Information |
7.22 AdverseEvent Type |
7.23 ClinicalTrialSignificantAdverseEvent |
7.24 Patient reported AE during research study |
7.25 adverse-event-compass-ex1 |
7.26 adverse-event-compass-ex1a |
7.27 adverse-event-compass-ex1b |
7.28 adverse-event-compass-ex2 |
7.29 AdverseEventFromProcedureNotStudyDrug |
7.30 SeriousAdverseEventResearchStudy |
7.31 NonSeriousAdverseEventResearchStudyMed |
7.32 adverse-event-device-death |
7.33 Serious Adverse Event |
7.34 ClinicalTrialSubject5 |
7.35 AEHepaticFailure |
7.36 AEHepaticFailurecomplication |
7.37 Janet Patient |
7.38 Breast Cancer Trial |
7.39 Janet weight Observation |
7.40 Janet Blood Pressure Observation |
7.41 Janet Tylenol PM med |
7.42 Janet allergy med |
7.43 Janet pill for water retention med not known |
7.44 Medication Administration for bresentrik |
7.45 Medication is bresentrik |
7.46 Medication Request for bresentrik |
7.47 Medication Administration of Med0301 |
7.48 Medication Request for discontinued clinical trial medication ABC |
7.49 Medication Request for discontinued clinical trial medication 0301 |
7.50 Problem |
7.51 patient-example-kaitlyn-b |
7.52 practitioner-oncology-nurse-jane |
7.53 practitioner-owen-oncologist |
7.54 medication-request-example-kadcyla |
7.55 medication-request-example-tucatinib |
7.56 medication-administration-kadcyla |
7.57 medication-administration-tucatinib |
7.58 clinical-trial-example-compass |
7.59 clinical-trial-example-subject |
7.60 medication-administration-kadcyla-reduced |
7.61 medication-administration-tucatinib-reduced |
7.62 medication-request-example-zofran |
7.63 GIBleed |
7.64 research-study-XYZ |
7.65 study-medication-ABC |
7.66 study-medication-administration-ABC |
7.67 procedure-upper-endoscopy |
7.68 research-study-DISNEY |
7.69 study-medication-MMD |
7.70 study-medication-administration-MMD |
7.71 medication-tylenol |
7.72 medication-administration-tylenol |
7.73 research-study-acme |
7.74 clinical-trial-acme-subject |
7.75 clinical-trial-acme-procedure |
7.76 study-medication-administration-WBY |
7.77 medication-contrast-dye |
7.78 medication-administration-contrast-dye |
7.79 medication-forhives |
7.80 medication-administration-forhives |
7.81 AEModeratehives |
7.82 resstudy-medication-WBY |
7.83 Patient MOUMIC |
7.84 AEHeadache |
7.85 Example patient SLP |
7.86 Device - Infuser that exploded |
7.87 clinical-trial-example-subject1 |
7.88 medication-administration-kadcyla1 |
7.89 medication-request-example-kadcyla1 |
7.90 patient-example-kaitlyn-b1 |